New developments in C5a receptor signaling
Open Access
- 1 July 2012
- journal article
- review article
- Published by Taylor & Francis in Cell Health and Cytoskeleton
- Vol. 4, 73-82
- https://doi.org/10.2147/chc.s27233
Abstract
Abstract: Complement activation usually results in the formation of complement fragment 5a (C5a) that interacts with its two receptors, C5aR and C5L2. These receptors belong to the rhodopsin family of G protein-coupled seven transmembrane-containing receptors. C5aR and C5L2 are expressed on/in a wide variety of cells and tissues. Interaction of C5a with C5aR leads to many pleiotropic effects, including the release of cytokines and chemokines and recruitment of inflammatory cells. In certain circumstances, C5a–C5aR interactions can also result in pathophysiological changes as seen in sepsis, rheumatoid arthritis, asthma, acute lung injury and ischemia-reperfusion injury. This overview of the C5a–C5aR interactions describes how such interactions facilitate the pivotal role the complement system plays in the host's innate and adaptive responses.Keywords
This publication has 82 references indexed in Scilit:
- Sphingosine-1-phosphate signaling and its role in diseaseTrends in Cell Biology, 2011
- β-arrestin-mediated receptor trafficking and signal transductionTrends in Pharmacological Sciences, 2011
- TLR activation enhances C5a‐induced pro‐inflammatory responses by negatively modulating the second C5a receptor, C5L2European Journal of Immunology, 2011
- The complement systemCell and tissue research, 2010
- A peptide mimic of the chemotaxis inhibitory protein of Staphylococcus aureus: towards the development of novel anti-inflammatory compoundsAmino Acids, 2010
- Teaching old receptors new tricks: biasing seven-transmembrane receptorsNature Reviews Drug Discovery, 2010
- The role of the anaphylatoxins in health and diseaseMolecular Immunology, 2009
- Functional roles for C5a receptors in sepsisNature Medicine, 2008
- Locally Produced Complement Fragments C5a and C3a Provide Both Costimulatory and Survival Signals to Naive CD4+ T CellsImmunity, 2008
- Complement-targeted therapeuticsNature Biotechnology, 2007